The stocks of Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) has been Initiated to Buy by Needham in its latest research note that was published on October 21. ZYNE was given a price target of $18, with other Wall Street analysts also giving their reports regarding the stock. The stock also received a Buy rating from Canaccord Genuity. This was contained in a research note published by the firm on April 22. The stock received a Buy rating and a price target of $23 in H.C. Wainwright’s research note that was published on February 01.
Zynerba’s stock is covered by 7 analysts, with 6 of them rating the stock as Buy. It has been deemed to have strong buy by none of the analysts, 1 of them have rated it as a Hold while none of them rated it as sell. The situation was different a month ago when the stock was rated as a Buy by only 5 analysts. None of them rated it as strong buy with 1 of them recommended investors to Hold on to the stock. Meanwhile, none analyst(s) rated it as a sell. The above data shows that ZYNE has an average analyst rating of Buy.
ZYNE surged by $0.10 during the normal trading session on Monday and reaching a high of $6.43 during the day while it closed the day at $6.16. The Zynerba stock had a low trading volume of 0.37 million shares on that day, which is low compared to the average daily volume of 708.06M shares. ZYNE has also lost 2.38% of its value over the past 7 days. However, the stock has declined by 41.56% in the 3 months of the year. Over the past six months meanwhile, it has lost 47.75% while it has added 107.41% year-on date.
Shares in South State Corporation (NASDAQ:SSB) jumped over 0.37 percent on Monday. The company’s stock began trading at $83.59 above the previous closing price of $83.28, and finished the day at $83.32. Let us now take a look at the stock’s potential support and resistance levels. The publicly traded company was seen to have slipped by -1.4% from its 3 months high price. However, taking another look at SSB will indicate that it is trading +16.69% away from its 90-day low. Looking at the bigger picture, the South State Corporation stock has dropped by -1.4% from its 52-week high while it has surged by +47.34% from its 52-week low price.
On November 06, 2019 RAINWATER KEITH S, Principal Accounting Officer sold 519 shares of the company. The average price for that transaction was $82 per share, which meant that RAINWATER KEITH S earned $42,558.00 selling the stocks. The sale was made public, with the document of the transaction filed with the SEC. Another insider trading occurred, with Director, ROQUEMORE JAMES W selling 4,791 shares of this stock on September 25, 2019. The average selling price for the stock was $76.15 per share, with the sold stock accruing $364,834.70. Following this transaction, the insider now holds 73,731 shares of the company, which is worth around $466,717.20.
Let us now take a quick look at the stock’s short, medium and long-term indicators. Composite Indicator shows that SSB stock was rated as a Buy by TrendSpotter. Its short-term indicators reveal that South has a 20-day average volume of 126690 shares. This has led to the SSB price forecast being placed as a 100% Buy on an average basis. In the medium term, however, the SSB stock has its 50-Day average volume of 135180 shares, with the indicators also rating it as a 100% Buy. Finally, in the long-term, the SSB stocks have a 100-Day average volume of 144297 shares, with the long-term indicators rating the stock as just 100% Buy. Looking at the three indicators, the SSB stock has been set on a 1 Buy rating.
Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 89.12%. This figure is better than the company’s 20-day Raw Stochastic average which currently stands at 74.89%. Over the past 20 days, South’s Stochastic %K stood at 81.46% while its Stochastic %D was revealed to be 85.36%.